for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sinovac's unit files application for public use of its COVID-19 vaccine to Chinese regulator

BEIJING, Feb 3 (Reuters) - Sinovac Biotech said on Wednesday its unit Sinovac Life Science has filed application for the public use of its COVID-19 vaccine to Chinese medical product regulator.

The application has been accepted by National Medical Products Administration for processing, Sinovac Biotech said in a statement. (Reporting by Roxanne Liu and Ryan Woo; Editing by Toby Chopra)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up